Current Outpatient Cardiac Rehabilitation in Austria

Completed

• Conditions: Cardiovascular Diseases

• Registration Number: NCT03463486
• Lead Sponsor: Paracelsus Medical University

Brief Summary

Aim of this study is to give evidence to outpatient cardiac rehabilitation in Austria. The database created in this context is supposed to pave the way as instrument to document and comprehend quality of outpatient cardiac rehabilitation in Austria as a key for quality management. Analyses of the created database should be made on a regular basis.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Study First Submitted: 2017-10-17
• Study First Submitted QC: 2018-03-06
• Study First Posted: 2018-03-13
• Primary Completion: 2018-12
• Study Completion: 2021-12
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-22
• Last Update Posted: 2022-04-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8000

Inclusion Criteria

Any patient who meets inclusion criteria for outpatient cardiac rehabilitation in Austria -

Exclusion Criteria

• Medical conditions which prevent patients from complying with the exercise program
• Acute infections
• Hypertrophic cardiomyopathy
• Pulmonary artery embolism or phlebothrombosis within the previous 6 months
• Unstable angina pectoris
• Heart failure (NYHA IV)
• Hemodynamically unstable arrhythmia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change from baseline in Physical Work Capacity (PWC) in Phase II rehabilitation	6 weeks	PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation
Change from baseline in Physical Work Capacity (PWC) in Phase III rehabilitation	1 year	PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation

Secondary Outcome Measures

Name	Time	Method
Change from baseline in Triglycerides in Phase III rehabilitation	1 year	Venous blood samples are taken to assess Triglycerides
Change from baseline in Cholesterol in Phase III rehabilitation	1 year	Venous blood samples are taken to assess Cholesterol
Change from baseline in Blood Glucose in Phase II rehabilitation	6 weeks	Venous blood samples are taken to assess blood glucose
Change from baseline in Triglycerides in Phase II rehabilitation	6 weeks	Venous blood samples are taken to assess Triglycerides
Change from baseline in Cholesterol in Phase II rehabilitation	6 weeks	Venous blood samples are taken to assess Cholesterol
Change from baseline in Blood Glucose in Phase III rehabilitation	1 year	Venous blood samples are taken to assess blood glucose

Trial Locations

Locations (1)

Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University; 🇦🇹 Salzburg, Austria